https://www.selleckchem.com/products/alc-0159.html
008). After a median follow-up of 3.95 (IQR 1.95-6.76) years, no difference was found in overall relapse rates according to baseline Eos, but those with HE experienced more neurologic (p= 0.013) and skin (p= 0.024) relapses and had more frequently peripheral neuropathy as damage at last follow-up (p= 0.02). Overall survival difference was not significantly different in patients with normal Eos or HE at diagnosis. (p= 0.08). Blood HE at diagnosis, observed in about one quarter of GPA patients, identifies a subgroup of patients with a mo
Like
Comment
Share
